A clinical perspective for practitioners working with chronic or treatment-resistant constipation.
Chronic constipation is something many practitioners struggle with — particularly when standard interventions simply don’t seem to shift it. In clinic, we often see patients who have tried magnesium, fibre, hydration and prokinetics, yet remain persistently constipated. In some cases, there may be partial improvement, but rarely full resolution.
These cases raise an important clinical question: is constipation always a motility disorder, or could other mechanisms be contributing?
Emerging research into the gut microbiome suggests that in some individuals, constipation may be driven not only by impaired motility, but also by microbial effects on intestinal muscle function and the integrity of the gut mucus layer. Understanding these mechanisms may help explain why certain patients remain resistant to conventional treatment approaches.
For a more patient-friendly explanation of these mechanisms, see our lay-friendly companion article on constipation and gut microbes.
The traditional model: constipation as a motility disorder
Historically, constipation has been understood primarily as a disorder of intestinal transit. Contributing factors typically include:
-
Reduced peristaltic activity
-
Autonomic nervous system dysregulation
-
Inadequate fibre intake
-
Insufficient fluid intake
-
Hormonal influences
-
Sedentary lifestyle
Accordingly, interventions tend to focus on stimulating motility or increasing stool bulk and hydration. These include magnesium and other osmotic laxatives, increased dietary fibre, prokinetic agents, and optimisation of hydration and nervous system regulation.
While these approaches are often effective, they do not address all underlying mechanisms. In particular, they may fail when constipation is driven by microbial influences rather than purely neuromuscular dysfunction.
Methane: a microbial regulator of intestinal motility
One of the most well-established microbial contributors to constipation is methane.
Methane is produced not by bacteria, but by methanogenic archaea in the gut. These organisms consume hydrogen produced by other microbes and convert it into methane gas. One of the dominant methanogens in the human gut is Methanobrevibacter smithii.
Methane is now recognised as a functional regulator of intestinal motility. Research suggests it can:
-
Slow the propagation of peristaltic waves
-
Increase baseline smooth muscle tone
-
Promote non-propulsive contractions
-
Reduce overall intestinal transit speed
The net effect is slower movement of intestinal contents, increased water absorption from stool, and the development of harder, more difficult-to-pass stools.
Clinically, methane-associated constipation is often characterised by:
-
Chronic constipation
-
Bloating
-
Slow transit
-
Incomplete evacuation
-
Partial or inconsistent response to fibre and osmotic agents
Importantly, methane does not simply reflect constipation — it may actively contribute to it.
The mucus layer: an overlooked factor in stool transit
While motility is clearly important, it is not the only determinant of normal bowel function. The intestinal mucus layer also plays a critical role.
This layer is composed primarily of mucin glycoproteins, which form a hydrated gel lining the intestinal surface. It serves several essential functions:
-
Lubricating stool to facilitate smooth transit
-
Reducing friction between stool and the intestinal wall
-
Protecting the epithelial barrier
-
Supporting a stable microbial environment
Adequate lubrication is essential for efficient stool passage. Even with normal motility, insufficient lubrication can make stool more difficult to pass.
This introduces an important clinical distinction: constipation may arise not only from impaired movement, but also from impaired lubrication.
Emerging research: microbial degradation of mucin
Recent research has highlighted the role of microbial enzymes in regulating the integrity of the mucus layer.
Certain gut microbes produce enzymes known as sulfatases, which remove sulfate groups from mucin molecules. These sulfate groups help stabilise mucin and protect it from degradation.
When these protective groups are removed, mucin becomes more vulnerable to breakdown. Over time, this can contribute to thinning of the mucus layer and reduced lubrication.
Reduced mucus integrity may lead to:
-
Increased friction during stool passage
-
Harder, drier stool
-
Increased straining
-
Constipation that does not respond fully to hydration or osmotic support
Experimental models have demonstrated that inhibiting microbial sulfatase activity preserves the mucus layer and prevents constipation, highlighting the importance of this mechanism.
Microbial fuel preference and mucin degradation
An important ecological principle underlies this process. Gut microbes preferentially ferment dietary fibres and other non-digestible carbohydrates. However, when these substrates are insufficient, microbes may instead utilise host-derived substrates such as mucin.
Low fibre intake, restrictive diets, and reduced microbial diversity may increase reliance on mucin as a fuel source. Over time, this may contribute to progressive thinning of the mucus layer and impaired stool lubrication.
This highlights the importance of viewing constipation not solely as a motility issue, but also as a reflection of microbial ecology and gut barrier integrity.
Distinguishing constipation subtypes in clinical practice
Recognising different constipation mechanisms may help explain variations in treatment response.
Motility-dominant constipation
This subtype is primarily driven by impaired neuromuscular function.
Typical characteristics include:
-
Infrequent stool
-
Slower transit
-
Good response to magnesium or prokinetics
-
Less pronounced stool dryness
These patients often respond well to conventional motility-focused interventions.
Methane-associated constipation
This subtype involves microbial slowing of motility.
Common features include:
-
Chronic constipation
-
Bloating
-
Slow transit
-
Partial response to magnesium or fibre
-
Frequent relapse
Addressing microbial factors may be necessary alongside motility support.
Lubrication-deficient (mucin-depletion) constipation
This subtype may be under-recognised in clinical practice.
Characteristics often include:
-
Dry, hard stool
-
Excessive straining
-
Sensation of stool being difficult to pass
-
Poor response to hydration and osmotic agents
-
History of restrictive diets, antibiotic use, or microbiome disruption
In these cases, impaired mucus integrity may be a key contributing factor.
Why conventional treatments sometimes fail
Standard interventions target hydration, stool bulk, or motility. However, they do not directly address microbial influences on mucus integrity or microbial regulation of motility.
For example:
-
Increasing fibre intake may not immediately restore mucus integrity if microbial ecology is disrupted
-
Magnesium may increase stool water content, but may not fully overcome lubrication deficits
-
Prokinetics may stimulate contractions, but may not resolve friction-related resistance
This may explain why some patients experience only partial or temporary improvement.
Clinical implications for functional medicine practitioners
These emerging mechanisms reinforce the importance of considering microbial ecology when working with chronic constipation.
This does not replace conventional approaches, but expands our understanding of the potential drivers involved.
Key considerations include:
-
Recognising that constipation is not always purely a motility disorder
-
Considering microbial contributions to motility regulation
-
Supporting microbial diversity and resilience
-
Ensuring adequate intake of fermentable substrates
-
Avoiding overly restrictive dietary approaches where possible
Supporting gut barrier integrity and microbial balance may play an important role in long-term resolution.
Conclusion: a shift in our understanding of constipation
Constipation is increasingly understood as a complex interaction between the nervous system, the microbiome, and the gut barrier.
Emerging research into methane production and microbial mucin degradation provides valuable insight into why some patients do not respond to conventional interventions. These findings highlight the microbiome as an active regulator of gut function, influencing both motility and lubrication.
For those interested in a more patient-friendly explanation of these concepts, see our lay-friendly companion article on constipation and gut microbes.
References
Hamaguchi, T., Gibo, N., Ohara, M., Ito, M., Ogura, T., Takeda, J. I., … Ohno, K. (2026). Bacterial constipation: Mucin-degrading intestinal commensal bacteria cause constipation. Gut Microbes, 18(1). https://doi.org/10.1080/19490976.2025.2596809